ESCRS - COVID-19 vaccine launched in Europe

COVID-19 vaccine launched in Europe

The European Union has begun to administer the COVID-19 vaccine developed by BioNTech and Pfizer to its 446 million citizens.

COVID-19 vaccine launched in Europe
Colin Kerr
Colin Kerr
Published: Sunday, December 27, 2020
The European Union has begun to administer the COVID-19 vaccine developed by BioNTech and Pfizer to its 446 million citizens. The vaccine was intended to be officially rolled out on Sunday December 27 but on Saturday December 26 Germany, Hungary and Slovakia began giving out their first coronavirus vaccine shots in advance of the European Union’s campaign for a coordinated rollout Sunday across the union's 27 nations. European Commission President Ursula von der Leyen said on Saturday that the Pfizer-BioNTech vaccine had been delivered to all 27 member states. "Today, we start turning the page on a difficult year. The #COVID19 vaccine has been delivered to all EU countries. Vaccination will begin tomorrow across the EU," Ms von der Leyen said in a tweet. "The #EUvaccinationdays are a touching moment of unity. Vaccination is the lasting way out of the pandemic," said Ms von der Leyen. The European Centre for Disease Prevention and Control (ECDC) has stated that in the initial phases of the vaccine deployment, it is expected that demand will exceed supply. "It will be important to manage expectations through appropriate communication regarding the choices of vaccine strategies. It will also be important to consider groups or settings that may have a disproportionate risk of exposure," said an ECDC spokesperson. "Given the many unknowns in relation to COVID-19 vaccines’ characteristics, deployment, supply, and uptake, non-pharmaceutical interventions should continue to be applied, as recommended by public health authorities, following the introduction of COVID-19 vaccination. Vaccination strategies will need to be adaptable over time to unfolding events taking into account the emerging evidence. ECDC will continue to monitor factors like COVID-19 vaccine effectiveness, confidence, uptake, supply, deployment, and future emerging variants that could have an impact on the response to COVID-19 vaccines," said the spokesperson. https://www.ecdc.europa.eu/en/news-events/ecdc-releases-vaccination-rollout-strategies-eueea
Latest Articles
Diamonds in the Rough

The push for inclusivity in ophthalmology.

Read more...

Making Female Leadership More than a Moment

A remarkable global confluence of women in key positions.

Read more...

ESCRS Talks Technology at AAO

Europe adopts technological advances, US still waiting for lenses and lasers.

Read more...

Sorting Out Simultaneous Vision IOLs

The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.

Read more...

Big Advantages to Small-Aperture IOLs

Small-aperture IOLs offer superior image quality with increased range of focus.

Read more...

Prioritising Self-Care

Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.

Read more...

Valuing Clinical Trial Design

How inclusivity and diversity can enhance scientific accuracy in research.

Read more...

Knowing Iris Repair: Using Iridodiathermy in Iris Surgery

Prepare for decentred pupils and uneven irides in multiple situations.

Read more...

Neuroprotectant Treatment for MacTel Type 2

Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.

Read more...

Supplement: Maximizing Visual Quality in Refractive Surgery Through Enhanced Precision and Safety

Read more...